Literature DB >> 16501210

Percutaneous coronary interventions with drug eluting stents for diabetic patients.

Ricardo Seabra-Gomes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16501210      PMCID： PMC1860831          DOI： 10.1136/hrt.2005.062992

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  27 in total

1.  Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.

Authors:  Manel Sabaté; Pilar Jiménez-Quevedo; Dominick J Angiolillo; Joan Antoni Gómez-Hospital; Fernando Alfonso; Rosana Hernández-Antolín; Javier Goicolea; Camino Bañuelos; Javier Escaned; Raúl Moreno; Cristina Fernández; Francisco Fernández-Avilés; Carlos Macaya
Journal:  Circulation       Date:  2005-10-04       Impact factor: 29.690

2.  Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Authors:  D L Bhatt; S P Marso; A M Lincoff; K E Wolski; S G Ellis; E J Topol
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

3.  A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes.

Authors:  Stuart N Hoffman; John A TenBrook; Michael P Wolf; Stephen G Pauker; Deeb N Salem; John B Wong
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

Review 4.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

Authors:  Joshua A Beckman; Mark A Creager; Peter Libby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

5.  Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

Authors:  Alban Dibra; Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Helmut Schühlen; Nicolas von Beckerath; Kurt Ulm; Rainer Wessely; Josef Dirschinger; Albert Schömig
Journal:  N Engl J Med       Date:  2005-08-16       Impact factor: 91.245

6.  A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.

Authors:  Mohan N Babapulle; Lawrence Joseph; Patrick Bélisle; James M Brophy; Mark J Eisenberg
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

7.  Evidence for use of coronary stents. A hierarchical bayesian meta-analysis.

Authors:  James M Brophy; Patrick Belisle; Lawrence Joseph
Journal:  Ann Intern Med       Date:  2003-05-20       Impact factor: 25.391

8.  Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention.

Authors:  Roberto A Corpus; Peter B George; John A House; Simon R Dixon; Steven C Ajluni; William H Devlin; Gerald C Timmis; Mamtha Balasubramaniam; William W O'Neill
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

9.  Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.

Authors:  Issam Moussa; Martin B Leon; Donald S Baim; William W O'Neill; Jeffery J Popma; Maurice Buchbinder; Jay Midwall; Charles A Simonton; Emily Keim; Patrick Wang; Richard E Kuntz; Jeffrey W Moses
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

10.  Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting.

Authors:  Jeremy Gilbert; Janet Raboud; Bernard Zinman
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112
View more
  12 in total

1.  Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.

Authors:  Eun-Jae Jang; In-Ho Bae; Dae Sung Park; So-Youn Lee; Kyung Seob Lim; Jun-Kyu Park; Jae-Won Shim; Doo Sun Sim; Myung Ho Jeong
Journal:  J Mater Sci Mater Med       Date:  2015-10-05       Impact factor: 3.896

Review 2.  Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

3.  Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry.

Authors:  Ajay K Jain; Chaim Lotan; Ian T Meredith; Faustos Feres; Robaayah Zambahari; Nakul Sinha; Martin T Rothman
Journal:  Heart       Date:  2010-06       Impact factor: 5.994

4.  Long-term type 1 diabetes enhances in-stent restenosis after aortic stenting in diabetes-prone BB rats.

Authors:  Geanina Onuta; Hendrik C Groenewegen; Flip A Klatter; Mark Walther Boer; Maaike Goris; Harry van Goor; Anton J M Roks; Jan Rozing; Bart J G L de Smet; Jan-Luuk Hillebrands
Journal:  J Biomed Biotechnol       Date:  2011-02-09

5.  Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry.

Authors:  Anurag Polavarapu; Raghava Sarma Polavarapu; Jayesh Prajapati; Asif Raheem; Kamlesh Thakkar; Shivani Kothari; Ashok Thakkar
Journal:  Int J Vasc Med       Date:  2015-09-02

6.  Comparison of 12-month clinical outcomes in diabetic and nondiabetic patients with chronic total occlusion lesions: a multicenter study.

Authors:  Seung-Woon Rha; Cheol Ung Choi; Jin Oh Na; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh; Hyeon-Cheol Gwon; Byeong-Keuk Kim; Hyo-Soo Kim; Cheol Woong Yu; Hun Sik Park; In-Ho Chae; Seung-Hwan Lee; Moo Hyun Kim; Seung-Ho Hur; Young-Keun Ahn; Yangsoo Jang
Journal:  Coron Artery Dis       Date:  2015-12       Impact factor: 1.439

Review 7.  Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study.

Authors:  Yong-Jin Jiang; Wei-Xing Han; Chao Gao; Jun Feng; Zheng-Fei Chen; Jing Zhang; Chun-Miao Luo; Jian-Yuan Pan
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus.

Authors:  Lei Guo; Rongchong Huang; Junjie Wang; Huaiyu Ding; Shaoke Meng; Xiaoyan Zhang; Haichen Lv; Lei Zhong; Jian Wu; Jiaying Xu; Xuchen Zhou
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

9.  Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.

Authors:  Tzu-Hsien Tsai; Chien-Ho Lee; Cheng-I Cheng; Yen-Nan Fang; Sheng-Ying Chung; Shyh-Ming Chen; Cheng-Jei Lin; Chiung-Jen Wu; Chi-Ling Hang; Wei-Yu Chen
Journal:  Cells       Date:  2019-06-14       Impact factor: 6.600

10.  Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.

Authors:  Jie Deng; Yaling Han; Mingyu Sun; Jie Tao; Chenghui Yan; Jian Kang; Shaohua Li
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.